10.7 C
London
Monday, September 26, 2022

Schedule Your Presentation to Thousands of Investors Now

Tag: CoronaVirus Vaccine

Scientist who helped develop Pfizer-BioNTech Covid vaccine agrees third shot is...

The chief medical officer of BioNTech (NASDAQ BNTX) told CNBC on Wednesday that people will likely need a third shot of its two-dose Covid-19 vaccine as immunity against the virus wanes, agreeing with previous comments made by Pfizer CEO Albert Bourla. Dr. Ozlem Tureci, co-founder and CMO of BioNTech, which developed a Covid vaccine with Pfizer (NYSE: PFE), said she also expects people will need to get vaccinated against the coronavirus annually, like for the seasonal flu.

Is it to late to buy Moderna after posting 40 Percent...

From January 2020 through January of this year, Moderna stock has dropped significantly three times. And each time, it recovered and climbed above its previous record high. It looks like that now may be happening for the fourth time. This may be a pattern of investors locking in profits, then repurchasing shares at a lower price -- and newcomers jumping aboard too.

As Kite seeks FDA approval on their Tecartus for Adult patients,...

Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, vertically integrated, leading CellTech bio-developer with potential blockbuster prospects in immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets.

Pfizer CEO says third Covid Vaccine dose likely needed with in...

As big pharma races to save millions of lives there is a smaller less known “sleeping giant” in the CAR-T space developing advanced S-layer technology with limitless applications in the key development of an intranasal vaccine.

Merck Spends 425 million on acquiring COVID 19 drug that ends...

Now, due to “regulatory uncertainties” and the time and resources needed to provide the additional data, Merck said it decided to discontinue the development of the drug and instead focus its efforts on advancing its other Covid-19 drug as well as accelerating production of the Johnson & Johnson vaccine.

Daily U.S. Covid cases remain above 70,000 amid Johnson & Johnson...

The rate of new U.S. coronavirus cases remains elevated as the country tries to ramp up its vaccination campaign following the distribution halt of Johnson & Johnson’s Covid-19 vaccine.The country is reporting about 71,200 new Covid cases per day, based on a seven-day average of data from Johns Hopkins University.

Warren Buffet buys into these 3 Pharma Companies overlooking a sleeping...

Spun off from Abbott Labs in 2013, AbbVie is one of the newer pharmaceutical companies on the market. However, the young company's management team wasted no time developing breakthrough drugs and driving sales to generate huge returns for shareholders.

Motley Fool recommends their top 3 healthcare stocks to buy right...

So far in 2021 Avalon GloboCare (NASDAQ:AVCO) has advanced there research platform substantially by expanding a Co-Development program with MIT using CRISPR based genome editing to combat cancer metastasis.

New To The Street is now Renewing 5 Clients

New to The Street has also just completed taping the first interview of a 12 Part Series featuring Healixa (EMOR) with CEO Ian Parker. Healixa is a Multifaceted company merging HealthTech and Fintech. Ian discusses with Jane the reason for the name change and how HealthTech and Fintech marry up.

CytoDyn (OTCQB: CYDY) Stuns FDA with 400% Improvement in 14 Day...

CytoDyn Inc. (OTCMKTS: CYDY) just released stunning numbers which takes the company down one of two roads.  The first road is a quick review by the FDA...